Standout Papers

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of ve... 2006 2026 2012 2019 3.3k
  1. Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery (2006)
    Michael S. Conte, Dennis F. Bandyk et al. Journal of Vascular Surgery
  2. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study (2010)
    Howard I. Scher, Tomasz M. Beer et al. The Lancet
  3. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy (2012)
    Howard I. Scher, Karim Fizazi et al. New England Journal of Medicine

Immediate Impact

25 from Science/Nature 107 standout
Sub-graph 1 of 15

Citing Papers

Pan-cancer whole-genome comparison of primary and metastatic solid tumours
2023 StandoutNature
STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma
2023 StandoutNature
30 intermediate papers

Works of Lynn Seely being referenced

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
2010 Standout

Author Peers

Author Last Decade Papers Cites
Lynn Seely 185 1248 3925 1286 15 5.1k
Mary Ellen Taplin 40 911 4080 950 27 5.0k
Matthew R. Smith 68 696 3274 1366 69 5.3k
J Horti 50 995 3561 1155 17 4.5k
Philip A. Watson 30 1809 3025 579 25 4.2k
William R. Berry 43 962 3834 1244 22 4.8k
John Wongvipat 49 3238 5051 972 35 7.3k
Vivek Arora 33 1919 3276 634 37 4.7k
Derek S. Welsbie 62 2713 3134 678 36 5.4k
Chris Tran 89 4357 3918 897 23 8.5k
Herbert C. Stary 132 1178 2065 1458 27 7.9k

All Works

Loading papers...

Rankless by CCL
2026